John Irving Bell - 02 Jan 2024 Form 3 Insider Report for Immunocore Holdings plc (IMCR)

Role
Director
Signature
/s/ John I. Bell
Issuer symbol
IMCR
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
3
Filing time
02 Jan 2024, 16:42:37 UTC
Next filing
28 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMCR Ordinary Shares 13,452 02 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMCR Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 6,915 $11.83 Direct F1
holding IMCR Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 1,335 $40.93 Direct F1
holding IMCR Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 1,335 $40.93 Direct F1
holding IMCR Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 18,215 $17.46 Direct F1
holding IMCR Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 33,985 $26.00 Direct F2
holding IMCR Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 14,176 $25.83 Direct F1
holding IMCR Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 8,676 $58.69 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately exercisable.
F2 25% of the shares subject to the option award vested on February 4, 2022, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
F3 100% of the shares subject to the option award shall vest on May 16, 2024, subject to the Reporting Person's continuous service through such vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney